The neutropenia grade correlated with higher risk, and patients with severe neutropenia (G3–4) in C1D14 or C2D1 had a higher risk of CDK4/6i dose reduction (p < 0.0001; OR 9.1; p < 0.0001; OR 13.9, respectively). Here, CDK4 is linked to neutropenia.